Novozymes A/S
General ticker "NVZMF" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $27.2B (TTM average)
Novozymes A/S follows the US Stock Market performance with the rate: 16.7%.
Estimated limits based on current volatility of 1.6%: low 64.49$, high 66.55$
Factors to consider:
- Company pays dividends (annually): last record date 2026-08-26, amount 0.37$ (Y0.56%)
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [44.08$, 63.69$]
- 2025-12-31 to 2026-12-31 estimated range: [44.59$, 64.16$]
Financial Metrics affecting the NVZMF estimates:
- Positive: with PPE of 24.9 at the end of fiscal year the price was neutral
- Positive: 11.29 < Operating profit margin, % of 13.07
- Positive: 2.37 < Operating cash flow per share per price, % of 4.13
- Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 1.97
- Positive: 69.38 < Shareholder equity ratio, % of 73.55 <= 81.92
- Positive: Interest expense per share per price, % of 0.31 <= 0.33
- Positive: 2.08 < Industry earnings per price (median), % of 2.34
- Negative: -0.33 < Industry inventory ratio change (median), % of -0.25
Short-term NVZMF quotes
Long-term NVZMF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | DKK17,553.00MM | DKK17,905.94MM | DKK3,830.79MM |
| Operating Expenses | DKK12,992.00MM | DKK13,928.50MM | DKK3,330.14MM |
| Operating Income | DKK4,561.00MM | DKK3,977.44MM | DKK500.65MM |
| Non-Operating Income | DKK-5.00MM | DKK-66.34MM | DKK-83.84MM |
| Interest Expense | DKK102.00MM | DKK23.24MM | DKK76.40MM |
| R&D Expense | DKK2,001.00MM | DKK2,017.79MM | DKK412.91MM |
| Income(Loss) | DKK4,556.00MM | DKK3,911.10MM | DKK416.80MM |
| Taxes | DKK870.00MM | DKK870.62MM | DKK111.22MM |
| Net Income(Loss)* | DKK3,676.00MM | DKK3,025.57MM | DKK305.37MM |
| Stockholders Equity | DKK13,837.00MM | DKK13,978.00MM | DKK11,176.00MM |
| Inventory | DKK3,772.92MM | DKK3,627.00MM | DKK720.60MM |
| Assets | DKK27,983.00MM | DKK28,391.00MM | DKK15,195.60MM |
| Operating Cash Flow | DKK4,006.00MM | DKK4,152.00MM | DKK1,019.90MM |
| Capital expenditure | DKK2,890.00MM | DKK2,056.00MM | DKK359.80MM |
| Investing Cash Flow | DKK-2,672.00MM | DKK-2,133.00MM | DKK-199.70MM |
| Financing Cash Flow | DKK-1,250.00MM | DKK-1,889.00MM | DKK-703.20MM |
| Earnings Per Share** | DKK13.19 | DKK10.89 | DKK0.67 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.